Δημοσίευση

Synergistic Effect of Ischemic Preconditioning and Antithrombin in Ischemia-Reperfusion Injury.

ΤίτλοςSynergistic Effect of Ischemic Preconditioning and Antithrombin in Ischemia-Reperfusion Injury.
Publication TypeJournal Article
Year of Publication2017
AuthorsVrakas, G., Tsalis K., Roidos G. Nikolaos, Christoforidis E., Kouzi-Koliakou K., Lazaridis C., & Vaidya A.
JournalExp Clin Transplant
Volume15
Issue3
Pagination320-328
Date Published2017 Jun
ISSN2146-8427
Λέξεις κλειδιάAnimals, Antithrombins, Biomarkers, Combined Modality Therapy, Cytokines, Disease Models, Animal, Hepatitis, Intestinal Diseases, Ischemic Preconditioning, Liver, Malondialdehyde, Mesenteric Artery, Superior, Neutrophil Infiltration, Peroxidase, Rats, Wistar, Reperfusion Injury, Splanchnic Circulation, Time Factors
Abstract

OBJECTIVES: Our study aimed to determine whether antithrombin plays a synergistic role in accentuating the effects of intestinal ischemic preconditioning.MATERIALS AND METHODS: Fifty rats were randomly allocated to 5 groups (10 rats/group) as follows: sham treatment (group 1); ischemia-reperfusion (group 2); ischemic preconditioning followed by ischemia-reperfusion (group 3); antithrombin + ischemia-reperfusion, similar to group 2 but including antithrombin administration (group 4); and antithrombin + ischemic preconditioning, similar to group 3 but including antithrombin administration (group 5). Blood samples and liver specimens were obtained for measurement of cytokines, myeloperoxidase, and malondialdehyde. Liver biopsies were examined by electron microscopy.RESULTS: Intestinal ischemia-reperfusion induced a remote hepatic inflammatory response as evidenced by the striking increase of proinflammatory cytokines, myeloperoxidase, and malondialdehyde. Tumor necrosis factor-α levels in group 5 (12.48 ± 0.7 pg/mL) were significantly lower than in group 3 (13.64 ± 0.78 pg/mL; P = .014). Mean interleukin 1β was lower in group 5 (9.52 ± 0.67pg/mL) than in group 3 (11.05 ± 1.9 pg/mL; P > .99). Mean interleukin 6 was also significantly lower in group 5 (17.13 ± 0.54 pg/mL) than in group 3 (23.82 ± 1 pg/mL; P ≤ .001). Myeloperoxidase levels were significantly higher in group 3 (20.52 ± 2.26 U/g) than in group 5 (18.59 ± 1.03 U/g; P = .025). However, malondialdehyde levels did not significantly improve in group 5 (4.55 ± 0.46 μmol) versus group 3 (5.17 ± 0.61 μmol; P = .286). Tumor necrosis factor-α, interleukin 6, and myeloperoxidase findings show that antithrombin administration further attenuated the inflammatory response caused by ischemia-reperfusion, suggesting a synergistic effect with ischemic preconditioning. These findings were confirmed by electron microscopy.CONCLUSIONS: The addition of antithrombin to ischemic preconditioning may act to attenuate or prevent damage from ischemia-reperfusion injury by inhibiting the release of cytokines and neutrophil infiltration.

DOI10.6002/ect.2015.0331
Alternate JournalExp Clin Transplant
PubMed ID28418287

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.